Vaishnaw Akshay

President of R&D Vaishnaw sold 12,246 shares at $49.57; stock down 4.4% from 52-week high amid $-102.2M annual loss

Akshay Vaishnaw, President of R&D, sold 12,246 shares (12.2K shares) of Scholar Rock at $49.57 on 2026-04-16, reducing his holdings by 1.9% to 630.5K shares. The sale occurred near the 52-week high ($50.01), with the stock currently down 4.4% from that peak. Scholar Rock posted a quarterly revenue of $33.2M against a full-year net income of $-102.2M, making the company unprofitable with revenue declining 100.0% year-over-year. In Vaishnaw's cross-ticker track record, his 7 prior sells achieved a 90-day well-timed rate of 85.71%; at Scholar Rock specifically, his sole prior sale on 2026-01-13 posted a 90-day return of +16.0%, indicating the stock rose after he sold—a poorly-timed outcome. The current sale near the 52-week high, against the backdrop of severe losses and negative revenue growth, merits investor attention to upcoming quarterly disclosures and R&D efficacy metrics.

SRRK: R&D President Vaishnaw sold 20,438 shares at $42.70 ($872.7K); retains 595.8K shares post-sale.

Akshay Vaishnaw, President of R&D, sold 20,438 shares of Scholar Rock (SRRK) at $42.70, reducing his holdings by 3.3% while retaining 595.8K shares. The sale occurred at a price $3.83 below the current market price of $46.53 and represents a modest position adjustment in a stock that has gained 66.5% over 90 days and risen 5.0% in the past month. Vaishnaw's cross-ticker track record shows a 100.00% well-timed selling rate across six prior transactions—though this metric reflects timing in prior sales and carries no necessary bearing on this specific trade. Scholar Rock remains unprofitable with a $-102.2M net loss in its latest full fiscal year, though the company has achieved strong 76.4% annual revenue growth; the sale occurs against this backdrop of ongoing losses alongside accelerating top-line expansion.